How Thermo Fisher Scientific Beat Wall Street Estimates in Q4

1 min read

Problems come joined at the hip with opportunities. Thermo Fisher Scientific (NYSE: TMO) has definitely found that to be the case with the COVID-19 pandemic. The company’s growth has accelerated and its stock has soared over the last 12 months thanks primarily to coronavirus testing.

That momentum should remain intact after Thermo Fisher reported its fourth-quarter and full-year 2020 results before the market opened on Monday. Here are the highlights from the company’s Q4 update.

Image Source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

AMC Continues to Rise — Should You Buy?

Next Story

Macao Gambling Revenue Was Down 63% in January

Latest from Blog